Jerome Wong - Jun 12, 2023 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Signature
/s/ Jerome Wong
Stock symbol
EKSO
Transactions as of
Jun 12, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 09:59 PM
Previous filing
Nov 17, 2022
Next filing
Aug 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +170K +167.61% $0.00 272K Jun 12, 2023 Direct F1, F2, F3
transaction EKSO Common Stock Award $0 +8.2K +255.21% $0.00 11.4K Jun 12, 2023 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 The RSU grant was approved by the Compensation Committee of the Board of Directors in a meeting held on December 5, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of December 5, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
F3 Includes 265,401 unvested RSUs.